Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and tolerability of dry powder tobramycin in non-cystic fibrosis bronchiectasis
2012-004437-16Phase 2Active
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tobramycin in bronchiectasis, sponsored by University Medical Center Groningen. Primary endpoint: Pharmacokinetic parameters of inhaled dry powder tobramycin. Started Mar 2013; status: active.
02
Drugs
tobramycin
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on 2012-004437-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004437-16.